Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13073781 | 0.72 | KMT2A (0.40) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL12435671 | 0.72 | ALOX15 (0.40) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL13034032 | 0.69 | KMT2A (0.50) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL37411 | 0.69 | ENPEP (0.39) | ALOX15BLMPMP22KMT2AANPEP | |
| SCHEMBL2576303 | 0.67 | ENPEP (0.38) | ALOX15BLMPMP22KMT2AANPEP | |
| SCHEMBL15793097 | 0.67 | — | — | |
| SCHEMBL12234122 | 0.64 | BLM (0.54) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL3277681 | 0.63 | TP53 (0.33) | KMT2AANPEPENPEP | |
| SCHEMBL3278910 | 0.62 | TP53 (0.33) | KMT2AANPEPENPEP | |
| SCHEMBL3338585 | 0.62 | TP53 (0.33) | KMT2AANPEPENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040133938-A1 | Use of lipoic acid in plant culture media | MONSANTO TECHNOLOGY LLC | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133938-A1 | Use of lipoic acid in plant culture media | TTPA, TST, LRAT | ALOX15 19/4885BLM 2715/4885PMP22 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.